Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Is it anti-D or anti-LW? A brief synopsis of the biology of the LW blood group and the importance and differential laboratory methods to discriminate these specificities. | Lab Med | 2025 | 40413616 | PubTator, text mining | PubMed |
| Diagnostic accuracy of cell-free DNA for the determination of fetal red blood cell antigen genotype: a systematic review and meta-analysis. | Am J Obstet Gynecol | 2025 | 40381796 | PubTator, text mining | PubMed |
| The RhCcEe phenotype incompatibility in Chinese and presence of DEL in serologically D-, C/E+ individuals. | Transfus Apher Sci | 2025 | 40373701 | PubTator, text mining | PubMed |
| [Identification of Jr(a-) rare blood type antibodies against anti-Jra: serological and molecular biology analysis and transfusion strategy]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 40350391 | PubTator, text mining | PubMed |
| Rhesus D Prophylaxis: When and Why We Give Rhesus D Immunoglobulin. | Obstet Gynecol Surv | 2025 | 40328690 | PubTator, text mining | PubMed |
| [Serological and Molecular Biological Detection of RhD Variants]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40326125 | PubTator, text mining | PubMed |
| Integrating RHD Genotyping for More Accurate Rh(D) Antigen Phenotyping: A Retrospective Study. | Medicina (Kaunas) | 2025 | 40282961 | PubTator, text mining | PubMed |
| Prevention of RhD alloimmunization in the first trimester of pregnancy: Clinical practice guidelines of the French College of Obstetricians and Gynecologists. | Int J Gynaecol Obstet | 2025 | 40251923 | PubTator, text mining | PubMed |
| Detecting red blood cell protein antigens by tandem mass spectrometry. | Transfusion | 2025 | 40237397 | PubTator, text mining | PubMed |
| Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification. | Haematologica | 2025 | 40207710 | PubTator, text mining | PubMed |
| Point-of-care determination of the frequency of Rhesus(D)-negative blood types and the uptake of anti(D) immunoglobulin among Rh(D)-negative women in Dadu district, Sindh, Pakistan. | PLOS Glob Public Health | 2025 | 40203017 | PubTator, text mining | PubMed |
| Weak D testing might be discontinued for RhD-negative blood donors with C and E negative phenotypes in the Indian population. | Transfus Apher Sci | 2025 | 40187294 | PubTator, text mining | PubMed |
| O blood usage trends in the pediatric population 2015-2019: A multi-institutional analysis. | Transfusion | 2025 | 40151072 | PubTator, text mining | PubMed |
| How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood. | Transfusion | 2025 | 40151013 | PubTator, text mining | PubMed |
| Prevalence of High Titre Anti-A and Anti-B Haemolysins Amongst Blood Group "O" Voluntary Donors at Mbale Regional Blood Bank, Eastern Uganda. | J Blood Med | 2025 | 40124215 | PubTator, text mining | PubMed |
| Identification of a novel variant (c.1-111A>G) located in GATA-1 motif of RHCE proximal promoter in two Chinese patients with the rare D-- phenotype. | Transfusion | 2025 | 40121670 | PubTator, text mining | PubMed |
| Perinatal outcomes in RhD-negative pregnant women in Japan. | Sci Rep | 2025 | 40121290 | PubTator, text mining | PubMed |
| Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. | Transfusion | 2025 | 40059673 | PubTator, text mining | PubMed |
| A prehospital protocol for transfusion of low-titer O-positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn. | Transfusion | 2025 | 40022726 | PubTator, text mining | PubMed |
| Clinical Performance of Cell-Free DNA for Fetal RhD Detection in RhD-Negative Pregnant Individuals in the United States. | Obstet Gynecol | 2025 | 40014864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=10